A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases
Clinical trial NCT07412691 · RECRUITING
Trial details
- NCT number
- NCT07412691
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-19
- Primary completion
- 2028-08-08
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.